Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High dose propranolol for challenging behaviors in ASD
NCT04047355Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Feb 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in Self-injurious behavior, behavioral disorder, sponsored by Rutgers University. Started Feb 2021; status: completed.
02
Drugs
propranolol
03
Conditions
Self-injurious behaviorbehavioral disorder
Beyond the preview
Go deeper on NCT04047355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04047355.